TrustCore Financial Services’s Myriad Genetics MYGN Stock Holding History

TrustCore Financial Services’s Portfolio MYGN Stock Details MYGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$609	Hold	42	–	–	﹤0.01%	961
2022 Q3	$1K	Hold	42	–	–	﹤0.01%	1008
2022 Q2	$1K	Hold	42	–	–	﹤0.01%	993
2022 Q1	$1K	Hold	42	–	–	﹤0.01%	998
2021 Q4	$1K	Hold	42	–	–	﹤0.01%	914
2021 Q3	$1K	Hold	42	–	–	﹤0.01%	988
2021 Q2	$1K	Hold	42	–	–	﹤0.01%	1023
2021 Q1	$1K	Hold	42	–	–	﹤0.01%	889
2020 Q4	$1K	Sell	42 -200	-83%	-$3.23K	﹤0.01%	875
2020 Q3	$3K	Hold	242	–	–	﹤0.01%	742
2020 Q2	$3K	Hold	242	–	–	﹤0.01%	770
2020 Q1	$3K	Hold	242	–	–	﹤0.01%	746
2019 Q4	$7K	Buy	242 +209	+633%	+$5.75K	﹤0.01%	693
2019 Q3	$1K	Buy	+33	New	+$962	﹤0.01%	911
2018 Q1	–	Sell	-100	Closed	-$3K	–	710
2017 Q4	$3K	Buy	+100	New	+$3.37K	﹤0.01%	604

Other funds holding MYGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

GCM

Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

DGI

Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

TrustCore Financial Services's MYGN Position: Q4 2022 in Review

TrustCore Financial Services held its Myriad Genetics (MYGN) position steady in Q4 2022 at 42 shares worth $609. The position accounts for ﹤0.01% of the portfolio, ranked #961.

TrustCore Financial Services first reported a position in MYGN in Q4 2017 and has held it in 15 quarters since. The position peaked at $7K in Q4 2019. 197 funds tracked by Wall St. Rank hold MYGN as of Q4 2022.

TrustCore Financial Services held 42 shares of Myriad Genetics worth $609 as of Q4 2022.
TrustCore Financial Services left its Myriad Genetics share count unchanged in Q4 2022.
Myriad Genetics made up ﹤0.01% of TrustCore Financial Services's portfolio in Q4 2022, its #961 holding.
TrustCore Financial Services first reported a position in Myriad Genetics in Q4 2017 and has held it in 15 quarters since.
TrustCore Financial Services's Myriad Genetics position peaked at $7K in Q4 2019.
197 funds tracked by Wall St. Rank held Myriad Genetics as of Q4 2022.

Based on TrustCore Financial Services's 13F filing for Q4 2022, filed 13 Feb 2023.